NCT01733004
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Marietta, Georgia, United States
- Boston, Massachusetts, United States
- Detroit, Michigan, United States
- Villejuif, France
Clinical trial condition
Insulin-Like Growth Factor I, Resistance To
Explore clinical trials studying Insulin-Like Growth Factor I, Resistance To. Study availability and eligibility vary by location and protocol.
14 public trials
3 recruiting studies
Insulin-Like Growth Factor I, Resistance To trial results
NCT00799240
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Hutchinson Clinic, PA Hutchinson, Kansas, United States
- Kansas University Cancer Center Kansas City, Kansas, United States
- Stormont Vail Healthcare Topeka, Kansas, United States
- VA Medical Center Kansas City, Missouri, United States
NCT00956436
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Resesarch Site Denver, Colorado, United States
- Resesarch Site Ocoee, Florida, United States
- Resesarch Site Indianapolis, Indiana, United States
- Resesarch Site Boston, Massachusetts, United States
Active, Not Recruiting
Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06866548
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China